Flagship Ventures Fund IV-Rx, L.P.
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Flagship Ventures Fund IV-Rx, L.P.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| 0001694665 | Purchase | 4,383,561 | $1.46 | $6,399,999 | May 27, 2022 | |
| MRNA | Other | 7,550,810 | — | — | Aug 17, 2020 | |
| 0001694665 | Purchase | 1,666,667 | $3.75 | $6,250,001 | Jun 29, 2020 | |
| MRNA | Other | 8,390,000 | — | — | May 11, 2020 | |
| MRNA | Sale | 27,714 | $18.99 | $526,289 | Dec 9, 2019 | |
| MCRB | C | 599,297 | — | — | Jun 26, 2015 |